Circulating tumor cell detection kit as well as preparation method and use method thereof
The folic acid modified CdS@Au nanoprobe and Fe3O4@HA nanocapture probe generated by using ion exchange technology in circulating tumor cell detection combined with dual recognition strategy and photothermal signal amplification, solves the problem of long detection time and high cost , realizes rapid and accurate detection and enrichment of circulating tumor cells.
Patent Information
- Application Number
- CN202411335588.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-24
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-09-24
AI Technical Summary
The prior art has problems of long detection time, high cost and complex biological environment interference in the detection of circulating tumor cells, and lacks efficient instant detection methods.
The folic acid-modified CdS@Au nanoprobe and Fe3O4@HA nanocapture probe generated based on ion exchange technology are used to achieve the enrichment and separation of circulating tumor cells through dual recognition strategies, and photothermal signal amplification is used to improve detection accuracy.
The rapid and accurate detection of circulating tumor cells is achieved, which reduces detection costs, improves the accuracy of detection results, and ensures effective enrichment and separation of circulating tumor cells.
Smart Images

Figure CN119044495A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of nano-biosensor technology, and in particular to an application of a dual recognition strategy based on ion exchange technology for real-time detection of circulating tumor cells. Background Art
[0002] Circulating tumor cells (CTCs) are malignant cells shed from tumor tissue into the peripheral blood or lymphatic system. They serve as a key indicator of cancer metastasis and can be used to demonstrate the development and metastasis of cancer. Studies have shown that CTCs can be detected in peripheral blood early in the development of cancer. Therefore, monitoring CTCs in the blood provides a valuable tool for early cancer diagnosis. However, the detection of CTCs in peripheral blood presents two significant challenges. First, the low number of CTCs in peripheral blood poses a significant challenge. Studies have reported that only a few to a few hundred CTCs are present in one milliliter of blood, far fewer than the number of blood cells. To address this issue, enrichment of CTCs in peripheral blood is crucial. A commonly used enrichment method for CTCs is the use of magnetic nanoprobes. Another challenge is the complex biological environment of peripheral blood, which poses significant challenges to CTC detection. Therefore, to improve the accuracy of detection results, CTCs can be isolated from peripheral blood. Immunomagnetic separation is also a promising method due to its high capture efficiency, rapid response, and ease of use.
[0003] Currently, instant detection methods based on different readout signals have been used for the detection of circulating tumor cells, such as colorimetry, electrochemistry, mass spectrometry, and blood glucose meter methods. The advantages of these detection methods are high accuracy and sensitivity, but they also have many disadvantages, such as long detection time, high detection cost, and large detection instruments that are not conducive to on-site detection. Therefore, we urgently need to develop new instant detection methods for the detection of circulating tumor cells.
[0004] While simple signals such as temperature, pressure, and pH have long been used in biosensing platforms, temperature-based photothermal detection platforms and dual-mode pressure-based point-of-care detection platforms have yet to be applied to the detection of circulating tumor cells. In photothermal detection platforms, the photothermal effect of the photothermal reagent plays a crucial role in the detection accuracy. There are two main sources of photothermal reagents: one is to directly apply the reagent prepared in an external environment to the detection platform. The other is to generate the photothermal agent in situ within the introduced detection material. This approach offers the advantage of improving the accuracy of detection results. However, in situ generation of photothermal reagents is often demanding, necessitating the development of new, milder methods for in situ generation. Ion exchange reactions are a promising candidate. CuS nanomaterials have attracted widespread attention as a promising photothermal reagent. Using CdS nanoparticles as the core, we achieved in situ generation of CuS nanoparticles through simple ion exchange. Simultaneously, gold nanoparticles were deposited on the surface of the CdS nanomaterials to modify the target head—folate—that targets circulating tumor cells. Signal amplification significantly improves the accuracy of detection results. Summary of the Invention
[0005] The purpose of the present invention is to provide a folic acid-modified CdS@Au nanoprobe generated based on ion exchange technology, a preparation method and application thereof, in response to the existing technology of how to achieve the capture and detection of circulating tumor cells through real-time detection technology.
[0006] The present invention is achieved in that: A circulating tumor cell detection kit comprises a FA-CdS@Au nanodetection probe and a Fe3O4@HA nanocapture probe.
[0007] A further improvement also includes a copper ion solution, wherein the copper ion solution is a copper chloride solution, and the mass concentration of the copper chloride solution is 1 mg / mL-2 mg / mL.
[0008] As a further improvement, the mass ratio of the FA-CdS@Au nano-detection probe and the Fe3O4@HA nano-capture probe is 1-4:1.
[0009] A method for preparing a circulating tumor cell detection kit comprises the following steps: Step 1: Preparation of FA-CdS@Au nano-detection probes; Step 2: Prepare Fe3O4@HA nanocapture probe.
[0010] As a further improvement, the preparation method of the FA-CdS@Au nano-detection probe is as follows: Step 1.1, silica nanospheres, sodium citrate aqueous solution, cadmium chloride solution, ammonia water and thiourea were sequentially added to a container and reacted at 80°C for 3 hours to obtain SiO2@CdS nanoparticles; Step 1.2, adding SiO2@CdS nanoparticles to a sodium hydroxide solution, and reacting at 90°C for 3 hours to remove silica to obtain CdS nanoparticles; Step 1.3, CdS nanoparticles are added to deionized water, and then polyvinyl pyrrolidone solution, tetrachloroauric acid solution and ascorbic acid solution are added in sequence, and the mixture is reacted at room temperature for three hours to obtain CdS@Au nanoparticles; Step 1.4: CdS@Au nanoparticles are dispersed in deionized water, and then FA-PEG-SH is added and reacted in the dark for 24 hours to obtain the FA-CdS@Au nanodetection probe.
[0011] Further improvement, the specific steps of step 1.1 are as follows: disperse the silica nanospheres in 100 ml of deionized water, ultrasonically disperse them uniformly, and then transfer them to a round-bottom flask, add a sodium citrate aqueous solution to the round-bottom flask and stir for 5 minutes, then add a cadmium chloride solution and stir again for 5 minutes, slowly add 2 ml of ammonia water and thiourea and react for 5 minutes, transfer the round-bottom flask to an 80°C oil bath and react for 3 hours to obtain SiO2@CdS nanoparticles after treatment; wherein the mass volume ratio of silica nanospheres, deionized water, sodium citrate aqueous solution, cadmium chloride solution, ammonia water and thiourea is 150:100:1:0.5:2:2 mg / ml; wherein the concentrations of the sodium citrate aqueous solution, cadmium chloride and thiourea are all 1 mol / L; the mass concentration of ammonia water is 28%; In the step 1.2, the concentration of the sodium hydroxide solution is 0.5 mol / L; In step 1.3, the mass volume ratio of CdS nanoparticles, deionized water, polyvinyl pyrrolidone solution, tetrachloroauric acid solution, and ascorbic acid solution is 10:10:1:3:4 mg / ml; wherein the mass concentration of the polyvinyl pyrrolidone solution and the tetrachloroauric acid solution is 0.1%; In the step 1.4, the CdS@Au nanoparticle solution is added to the FA-PEG-SH solution at a mass concentration ratio of 2:1 and a volume ratio of 1:1.
[0012] As a further improvement, the preparation method of the Fe3O4@HA nano-capture probe is as follows: Step 2.1. Add FeCl3.6H2O, FeCl2.4H2O, and HA to a container, then add deionized water, stir evenly, and heat under reflux at 100 degrees Celsius under nitrogen for 15 minutes to obtain a mixed solution; Step 2.2, adding NaOH solution to the mixed solution, reacting at 100 degrees Celsius for 1 hour under nitrogen protection to obtain a reaction solution; Step 2.3: The reaction solution was transferred to a reactor and aged at 150°C for 24 h. After aging, the solution was placed in a dialysis bag and dialyzed for 2 days to obtain the Fe3O4@HA nanocapture probe.
[0013] Further improvement, in step 2.1, the mass volume ratio of FeCl3.6H2O, FeCl2.4H2O, HA and deionized water is 0.36:0.132:30:32.5 g / ml; In step 2.2, the mass ratio of NaOH to HA in the NaOH solution is 1000:30.
[0014] A method for using the above-mentioned circulating tumor cell detection kit is characterized by comprising the following steps: S1, adding cancer cells to a multi-well plate for plating; S2, adding FA-CdS@Au nano-detection probes and Fe3O4@HA nano-capture probes, and then placing them in a shaker for incubation for 30 minutes, followed by magnetic separation, washing away excess sample solution, adding PBS solution to obtain a test solution, and then adding copper chloride solution to the test solution, and ultrasonically reacting for 10 minutes to obtain a test solution; S3, testing the test solution: S3.1 When the detection method is photothermal: irradiate the test solution with a 1064 nm laser for 10-15 minutes, and use an infrared thermal imager to capture the temperature change and record the temperature difference; 3.2 When the test method is pressure method: weigh 20-100 mg of ammonium bicarbonate in a sealed pressure bottle, add the test solution, and irradiate with a 1064 nm laser for 10-15 minutes. The pressure change at different time periods is recorded by a barometer.
[0015] As a further improvement, in step S1, the cancer cell concentration is 10 cells / mL-10 W cells / mL; the concentration ratio of FA-CdS@Au nanodetection probe and Fe3O4@HA nanocapture probe is 800 μg / mL:200 μg / mL, the volume ratio is 1:1, the added volume of FA-CdS@Au nanodetection probe and Fe3O4@HA nanocapture probe is 1-4:1; the volume ratio of FA-CdS@Au nanodetection probe to cancer cells is 1:9.
[0016] This invention uses a dual-probe recognition strategy to detect circulating tumor cells. The capture probe, Fe3O4@HA, is based on Fe3O4 magnetic nanoparticles. HA, as a target, specifically recognizes and binds to CD44, enabling the enrichment and isolation of rare circulating tumor cells in the blood. The detection probe, FA-CdS@Au, specifically recognizes and binds to the FR receptor. Addition of a copper chloride solution, which provides copper ions, triggers ion exchange, generating FA-CuS@Au with excellent photothermal properties. Through the interaction of these two nanoprobes, the biorecognition signal between the receptor ligand is converted into simpler signals (temperature and pressure). This effectively improves the accuracy of circulating tumor cell detection results.
[0017] Advantages and benefits of the present invention: The present invention can synthesize a uniformly shaped and stable detection probe, FA-CdS@Au, and a capture probe, Fe3O4@HA, with excellent magnetic properties. The magnetic properties of the capture probe are used to separate circulating tumor cells from other blood cells. Detection of circulating tumor cells is then achieved by transforming FA-CdS@Au into FA-CuS@Au, establishing a relationship between changing temperature and pressure and circulating tumor cell concentration. In this method, the establishment of a dual recognition probe strategy ensures the effective enrichment and separation of circulating tumor cells. The in situ generation of FA-CuS@Au, with its excellent photothermal properties, enables signal amplification, improving the accuracy of experimental results. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 (a) is a schematic diagram of the synthesis routes and principles of FA-CdS@Au in Example 1 and Fe3O4@HA in Example 2 of the present invention; Figure 1 (b) is a schematic diagram showing the principle of using FA-CdS@Au in Example 1 and Fe3O4@HA in Example 2 for dual recognition strategy detection of circulating tumor cells; Figure 2 The scanning electron microscopy (SEM) image, transmission electron microscopy (TEM) image, high-resolution transmission electron microscopy (HRTEM) image, and elemental mapping image of CdS@Au NPs in Example 2 of the present invention are shown; Figure 3 is the X-ray diffraction pattern of CdS@Au NPs in Example 2 of the present invention; Figure 4 is the X-ray photoelectron spectrum of CdS@Au NPs in Example 2 of the present invention; Figure 5 is a UV comparison diagram of CdS@Au NPs and CuS@Au in Example 3 of the present invention; Figure 6 This is a time-optimized UV spectrum of the process of copper ions replacing cadmium ions in a copper chloride solution to generate CuS@Au NPs in Example 3 of the present invention; Figure 7-10 Graphs showing the results of the photothermal performance test of CuS@Au NPs generated by substitution in Example 3 of the present invention under 1064 nm laser irradiation; Figure 11-13 Graphs showing the results of the pressure performance test of CuS@Au NPs generated by substitution in Example 3 of the present invention under 1064 nm laser irradiation; Figure 14 is a comparison chart of the ultraviolet spectra of FA-CdS@Au, FA and CdS@Au in Example 3 of the present invention; Figure 15 is the X-ray diffraction pattern of Fe3O4@HA in Example 10 of the present invention; Figure 16 is a graph showing the particle size of Fe3O4@HA in Example 10 of the present invention; Figure 17 This is a temperature change diagram showing the feasibility of using FA-CdS@Au as a detection probe and Fe3O4@HA as a capture probe for a dual recognition strategy to detect circulating tumor cells in Example 10 of the present invention; Figure 18 10. This is a photothermal result diagram of the FA-CdS@Au method for detecting circulating tumor cells at different cell concentrations under 1064 nm laser irradiation in Example 10 of the present invention; Figure 19 This is a graph showing the pressure results of detecting circulating tumor cells of different cell concentrations using the pressure detection method of FA-CdS@Au under 1064 nm laser irradiation in Example 10 of the present invention. DETAILED DESCRIPTION
[0019] To facilitate understanding of the present invention, the present invention will be described more fully below with reference to the accompanying drawings. Preferred embodiments of the present invention are shown in the drawings. However, the present invention may be embodied in many different forms and is not limited to the embodiments described herein. Rather, these embodiments are provided to provide a more thorough and comprehensive disclosure of the present invention.
[0020] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art in the art of the present invention. The terms used in the specification are only for describing specific implementation purposes and are not intended to limit the present invention. Example 1:
[0021] See also Figure 1 As shown in (a), the present invention provides a method for preparing a folic acid-modified CdS@Au nano-detection probe and a hyaluronic acid-modified Fe3O4 nano-capture probe.
[0022] The preparation method of FA-CdS@Au nano-detection probe includes the following steps: Step 1: Dissolve 150 mg of silica nanospheres in 100 ml of deionized water, ultrasonically disperse them, and transfer the solution to a round-bottom flask. Add 1 ml of a 1 mol / L sodium citrate solution to the round-bottom flask and stir for 5 minutes. Then, add 0.5 ml of a 1 mol / L cadmium chloride solution and stir again for 5 minutes. Then, slowly add 2 ml of ammonia and 1 mol / L thiourea and react for 5 minutes. Transfer the round-bottom flask to an 80°C oil bath and react for 3 hours to obtain SiO2@CdS nanoparticles. Step 2: Dissolve the SiO2@CdS nanoparticles obtained in step 1 uniformly in 50 ml of a 0.5 mol / L sodium hydroxide aqueous solution, react in an oil bath at 90°C for 3 hours to remove the silica nanoparticles, and obtain CdS nanoparticles after treatment.
[0023] Step 3: Weigh 10 mg of the CdS nanoparticles prepared in Step 2 and evenly disperse them in 10 ml of deionized water. Once dispersed, add 1 ml of a 0.1% aqueous solution of PVP, followed by 3 ml of a 0.1% aqueous solution of tetrachloroauric acid. Stir thoroughly, then quickly add 4 ml of a 0.01 mol / L ascorbic acid solution. Allow to react at room temperature for 3 hours to obtain CdS@Au nanoparticles.
[0024] Step 4: Disperse the CdS@Au nanoparticles obtained in Step 3 above in 1 ml of deionized water. After sonication, add an equal volume of FA-PEG-SH solution (a polyethylene glycol thiol solution modified with folic acid (FA)). Incubate in the dark at room temperature for 24-48 hours to obtain FA-CdS@Au nanoparticles. The concentration ratio of CdS@Au to FA-PEG-SH solution is 2:1 (1.6 mg / mL: 0.8 mg / mL).
[0025] The preparation method of Fe3O4@HA nanocapture probe includes the following steps: Step 1: Add 0.36 g FeCl3.6H2O, 0.132 g FeCl2.4H2O and 30 mg HA to a three-necked flask, add 32.5 ml deionized water, stir evenly, and heat under reflux to 100 degrees Celsius under nitrogen protection for 15 minutes.
[0026] Step 2: Use a syringe to quickly add 10 ml of a solution containing 1 g of NaOH into the solution and react at 100 degrees Celsius for 1 hour under nitrogen protection.
[0027] Step 3: Transfer the reactants to a reactor and age them at 150°C for 24 hours. After aging, place the solution in a dialysis bag and dialyze for 2 days to obtain Fe3O4@HA nanoparticles. Example 2:
[0028] Characterization of FA-CdS@Au: The CdS@Au nanoparticles synthesized in Example 1 were dried and characterized by scanning electron microscopy and transmission electron microscopy. Figure 2 As shown in Figure 2, scanning electron microscopy and transmission electron microscopy images show that the synthesized CdS@Au nanoparticles are regular round in shape, well dispersed, and uniform in size. Au nanoparticles are dispersed on the surface of the CdS nanoparticles. High-resolution electron microscopy images show that the CdS@Au nanoparticles have two different lattice spacings, namely 0.355nm corresponding to the 100 crystal plane of CdS and 0.240nm corresponding to the 111 crystal plane of Au. Figure 2 As shown. The element mapping of CdS@Au nanoparticles shows that Cd, S and Au elements are evenly distributed, as shown Figure 2 shown.
[0029] The CdS@Au and CdS nanoparticles synthesized in Example 1 were subjected to X-ray diffraction comparative analysis. Figure 3 As shown in the figure, the peaks of both are consistent with those of the standard card of CdS and the standard card of Au, which proves the successful synthesis of CdS@Au NPs.
[0030] The CdS@Au NPs synthesized in Example 1 were subjected to X-ray photoelectron spectroscopy analysis. Figure 4 As shown, the X-ray photoelectron spectroscopy shows the presence of corresponding copper, sulfur and gold elements in the synthesized CdS@Au. Example 3:
[0031] Feasibility experiment and condition optimization experiment of CuS@Au nanoparticles generated by replacing cadmium ions with copper ions (1) The CdS@Au prepared in Example 1 was dispersed in deionized water and its concentration was quantified. The same volume of copper chloride solution was added to the quantified CdS@Au solution. After ultrasonic reaction for a certain period of time, the solution was subjected to UV measurement. Figure 5 As shown in the figure, after adding copper chloride solution, the UV absorbance of CdS@Au changes in the range of 300-1100 nm. The absorbance of CuS@Au formed at 445 nm is significantly higher than that of CdS@Au.
[0032] (2) Optimize the replacement time of copper ions for cadmium ions to generate CuS@Au. Add the same volume of copper chloride solution to the quantitative CdS@Au solution, and group them into groups and react for different times (1, 5, 10, 20, 30 and 40 minutes) in an ultrasonic instrument. UV measurement is then performed on the solutions in different groups. Figure 6 As shown in the figure, the absorbance of CuS@Au at 1064 nm increases with time and tends to be stable after 10 min, so the optimal replacement time is selected as 10 min. Example 4:
[0033] Photothermal performance test of CuS@Au generated by substitution: The same volume of copper chloride solution was added to the quantitative CdS@Au solution, and after ultrasonic reaction for 10 min, the solution was placed under a light power density (1.0 W / cm 2 ) was irradiated with a 1064 nm laser for 10 min. The temperature changes of CuS@Au solutions (0 μg / mL, 25 μg / mL, 50 μg / mL, 100 μg / mL, 150 μg / mL, 200 μg / mL, 300 μg / mL, 400 μg / mL) generated by CdS@Au substitution at different concentrations under laser irradiation were captured using an infrared thermal imager and the time-temperature curve was plotted. Figure 7 As shown in the figure, with the increase of the concentration of CdS@Au solution, the amount of CuS@Au generated increases, the temperature change of the solution gradually increases, and when the concentration of CdS@Au is 200μg / mL, the temperature change tends to be flat. Therefore, a CdS@Au concentration of 200μg / mL is selected as the optimal concentration for subsequent experiments.
[0034] The same volume of copper chloride solution was added to the quantitative CdS@Au solution, and after ultrasonic reaction for 10 min, the solution was placed under different light power densities (0.5 W / cm 2 , 1.0W / cm 2 , 1.5W / cm 2 , 2.0W / cm 2 , 2.5W / cm 2 、3W / cm 2 ) was irradiated with a 1064 nm laser for 10 min. The temperature change of the CuS@Au solution generated by CdS@Au substitution with the same concentration under laser irradiation was captured using an infrared thermal imager and a time-temperature curve was plotted. Figure 8 As shown in Figure 2, with the increase of laser power, the temperature change of the solution gradually increases, and when the laser power density is 2.0W / cm 2 When the temperature changes, it tends to be gentle, so the laser power density is selected to be 2.0W / cm 2As the optimal laser power density for subsequent experiments.
[0035] (3) In order to detect the photothermal stability of CuS@Au nanomaterials generated by substitution, the same volume of copper chloride solution was added to the CdS@Au (200 μg / mL) solution. After ultrasonic reaction for 10 min, the substituted solution was laser-excited at 1064 nm (laser power density of 2.0 W / cm 2 ) After three cycles of irradiation, the heating-cooling curve was obtained. Figure 9 As shown, the CuS@Au generated by substitution has good photothermal stability and is relatively stable under light conditions.
[0036] Figure 7-10 The results of the photothermal performance test of the replacement-generated CdS@Au under 1064nm laser irradiation. Example 5:
[0037] Pressure performance test of CuS@Au generated by substitution: 20 mg of NH4HCO3 was weighed and placed in a pressure bottle. Quantitatively added CdS@Au solutions of different concentrations (0 μg / mL, 50 μg / mL, 100 μg / mL, 200 μg / mL, 300 μg / mL, 400 μg / mL) to the EP tube, and then the same volume of copper chloride solution was added. Ultrasonic reaction was carried out for 10 min. The solution in the EP tube was transferred to the pressure bottle and placed in a vacuum chamber with a light power density of 2.0 W / cm 2 ) laser for 10 min. Use a portable barometer to record the pressure change in the bottle and draw a time-pressure change curve. Figure 11 As shown in the figure, under 1064nm laser irradiation, as the concentration of the CdS@Au solution increases, more CuS@Au is generated, the solution temperature gradually increases, and the gas produced by the decomposition of NH4HCO3 increases. Ultimately, the pressure change in the container increases. At a CdS@Au concentration of 200μg / mL, the pressure change amplitude decreases. Ultimately, a CdS@Au concentration of 200μg / mL was selected as the optimal concentration for the pressure performance test, which is the same as the optimal concentration obtained in the photothermal experiment.
[0038] Different masses of NH4HCO3 (20 mg, 40 mg, 60 mg, 80 mg, and 100 mg) were added to a sealed pressure bottle. A quantitative amount of CdS@Au solution was added to an EP tube, followed by the addition of the same volume of copper chloride solution. The reaction was ultrasonically reacted for 10 min, and the solution in the EP tube was transferred to a pressure bottle. The solution was stirred at 2.0 W / cm 2 Irradiate the bottle with 1064 nm laser for 10 min, use a portable barometer to record the pressure change in the bottle and draw a time-pressure change curve. Figure 12As shown in the figure, after the solution was irradiated for 10 min, the pressure increased with the increase of the mass of NH4HCO3. Finally, the mass of NH4HCO3 of 80 mg was selected as the optimal condition for the experiment.
[0039] The ability of CuS@Au generated by substitution under different conditions to decompose NH4HCO3 was tested, such as Figure 13 As shown in Figure 3, the pressure change caused by the decomposition gas is the largest only when CdS@Au, copper chloride solution, 1064 nm laser and ammonium bicarbonate are all present.
[0040] Figure 11-13 The results of the photothermal performance test of the replacement-generated CdS@Au under 1064nm laser irradiation. Example 6:
[0041] Characterization of detection probe FA-CdS@Au and capture probe Fe3O4@HA (1) The FA-CdS@Au nanoparticles synthesized in Example 1 were dispersed in deionized water and quantified. The UV spectra of the synthesized FA-CdS@Au were compared with those of FA and CdS@Au. Figure 14 As shown, it can be seen that FA-CdS@Au exhibits characteristic peaks of FA and CdS@Au at 245nm and 268nm, respectively, proving the successful synthesis of FA-CdS@Au.
[0042] (2) The Fe3O4@HA nanoparticles synthesized in Example 1 were subjected to X-ray diffraction comparative analysis. Figure 15 As shown in the figure, the peaks of Fe3O4@HA are consistent with those of the standard card of Fe3O4, which proves the successful synthesis of Fe3O4@HA.
[0043] (3) The Fe3O4@HA nanoparticles synthesized in Example 1 were tested for hydrated particle size. Figure 16 As shown in the figure, the average particle size of the synthesized Fe3O4@HA is 94 nm and the dispersion is good. Example 7:
[0044] The present invention also provides the detection probe FA-CdS@Au and the capture probe Fe3O4@HA prepared in Example 1 for use in temperature / pressure dual-mode detection of circulating tumor cells (MDA-MB-231).
[0045] First, a feasibility study was conducted on the detection probe FA-CdS@Au and the capture probe Fe3O4@HA for the immediate detection of circulating tumor cells (MDA-MB-231): A certain concentration of MDA-MB-231 cells was plated in a 12-well plate, and 200 μg / mL of FA-CdS@Au and Fe3O4@HA nanoprobes were added according to different conditions. The plate was placed on a shaker and shaken for one hour, and then subjected to magnetic separation. After the magnetic separation was complete, the unbound probe solution was discarded and the cells were rinsed three times with PBS solution. 1 ml of PBS was added to each well, mixed well, and the solution was transferred to an EP tube for testing. Figure 17 As shown in the figure, under different conditions, the detected temperature change is the highest only when the detection probe FA-CdS@Au, the capture probe Fe3O4@HA, cells and copper chloride solution provide copper ions, and all four are present, indicating that FA-CdS@Au and Fe3O4@HA nanoprobes can be used for the capture and detection of circulating tumor cells (MDA-MB-231).
[0046] The detection probe FA-CdS@Au and the capture probe Fe3O4@HA are used for temperature / pressure dual-mode detection of circulating tumor cells, which specifically includes the following detection steps: (1) MDA-MB-231 cells were plated in 12-well plates at cell concentrations of 10 W cells / mL, 5 W cells / mL, 1 W cells / mL, 5000 cells / mL, 1000 cells / mL, 500 cells / mL, 100 cells / mL, 50 cells / mL, and 10 cells / mL; (2) Add the detection probe FA-CdS@Au and the capture probe Fe3O4@HA to the cells at different concentrations in step (1) at 800 μg / mL and 200 μg / mL, respectively. After administration, seal the well plate and place it on a shaker for 30 minutes to allow the probe to fully bind to the cells. After shaking for 30 minutes, use a magnet to absorb the bottom of the well plate and discard the upper liquid. Carefully rinse with PBS three times, and add 1 ml of PBS to each well. Transfer the liquid to an EP tube for testing; (3) Photothermal detection of circulating tumor cells: irradiate the test solution with a 1064 nm laser for 10 min, and use an infrared thermal imager to capture temperature changes and record the temperature difference; (4) Detection of circulating tumor cells by pressure method: Weigh 80 mg / mL ammonium bicarbonate into a sealed pressure bottle, add 500 μL of the test solution, irradiate with a 1064 nm laser for 10 min, and record the pressure changes with a portable pressure gauge.
[0047] For step (3) and step (4), it is necessary to further explain that Figure 1 As shown in (b), the detection probe FA-CdS@Au and the capture probe Fe3O4@HA in the present invention are used for temperature / pressure dual-mode detection of circulating tumor cells: Circulating tumor cells (MDA-MB-231) possess phagocytic glycoprotein-1 (CD44) and folate receptor (FR) on their surfaces. The capture probe Fe3O4@HA specifically recognizes and binds to CD44. Its magnetic properties allow it to enrich MDA-MB-231 circulating tumor cells and separate them from other cells. Simultaneously, the detection probe FA-CdS@Au specifically recognizes and binds to FR. Upon addition of a copper chloride solution, a displacement reaction occurs to produce FA-CuS@Au, which exhibits excellent photothermal properties. Under laser irradiation, FA-CuS@Au increases the solution temperature, enabling temperature detection of circulating tumor cells. Furthermore, the elevated temperature decomposes ammonium bicarbonate, enabling pressure detection of circulating tumor cells.
[0048] Finally, a standard curve was drawn with the concentration of MDA-MB-231 cells as the horizontal axis and the temperature change of the solution as the vertical axis. The regression equation of the standard curve in temperature detection was: y=4.3383Logx+1.8415, and the correlation coefficient R 2 =0.9958, and the minimum detection limit of temperature detection is calculated to be 6 Cells / mL; the regression equation of the standard curve in pressure detection is: y=2.9816Logx+8.2971, and the regression coefficient R 2 =0.9922y=4.3383, and the minimum detection limit of pressure detection is 5 cells / mL; Figure 18 This figure shows the results of detecting circulating tumor cells of different concentrations using the detection probe FA-CdS@Au and the capture probe Fe3O4@HA by temperature detection under 1064nm laser irradiation. Figure 19 This figure shows the results of detecting circulating tumor cells with different concentrations using the detection probe FA-CdS@Au and the capture probe Fe3O4@HA through pressure detection under 1064nm laser irradiation.
[0049] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.
Claims
1. A circulating tumor cell detection kit, characterized in that: Including FA-CdS@Au nano-detection probe and Fe3O4@HA nano-capture probe.
2. The circulating tumor cell detection kit according to claim 1, characterized in that It also includes a copper ion solution, which is a copper chloride solution, and the mass concentration of the copper chloride solution is 1 mg / mL-2 mg / mL.
3. The circulating tumor cell detection kit according to claim 1, characterized in that The mass ratio of the FA-CdS@Au nano-detection probe and the Fe3O4@HA nano-capture probe is 1-4:
1.
4. A method for preparing a circulating tumor cell detection kit, characterized in that: The steps include: Step 1: Preparation of FA-CdS@Au nano-detection probe; Step 2: Prepare Fe3O4@HA nano-capture probe.
5. The method for preparing the circulating tumor cell detection kit according to claim 4, characterized in that: The preparation method of the FA-CdS@Au nano detection probe is as follows: Step 1.1, adding silica nanospheres, sodium citrate aqueous solution, cadmium chloride solution, ammonia water and thiourea into a container in sequence, reacting at 80° C. for 3 hours to obtain SiO2@CdS nanoparticles; Step 1.2, adding SiO2@CdS nanoparticles into a sodium hydroxide solution, reacting at 90°C for 3 hours to remove silicon dioxide, thereby obtaining CdS nanoparticles; Step 1.3, CdS nanoparticles are added to deionized water, and then polyvinyl pyrrolidone solution, tetrachloroauric acid solution and ascorbic acid solution are added in sequence, and reacted at room temperature for three hours to obtain CdS@Au nanoparticles; Step 1.4, CdS@Au nanoparticles are dispersed in deionized water, and then FA-PEG-SH is added to react for 24 hours in the dark to obtain the FA-CdS@Au nano detection probe.
6. The method for preparing the circulating tumor cell detection kit according to claim 5, characterized in that: The specific steps of step 1.1 are as follows: dispersing silica nanospheres in 100 ml of deionized water, uniformly dispersing by ultrasonication, and then transferring to a round-bottom flask, adding sodium citrate aqueous solution to the round-bottom flask and stirring for 5 min, then adding cadmium chloride solution and stirring again for 5 min, slowly adding 2 ml of ammonia water and thiourea and reacting for 5 min, transferring the round-bottom flask to an oil bath at 80°C and reacting for 3 hours, and obtaining SiO2@CdS nanoparticles after treatment; wherein the mass volume ratio of silica nanospheres, deionized water, sodium citrate aqueous solution, cadmium chloride solution, ammonia water and thiourea is 150:100:1:0.5:2:2 mg / ml; wherein the concentrations of sodium citrate aqueous solution, cadmium chloride and thiourea are all 1 mol / L; and the mass concentration of ammonia water is 28%; In the step 1.2, the concentration of the sodium hydroxide solution is 0.5 mol / L; In the step 1.3, the mass volume ratio of CdS nanoparticles, deionized water, polyvinyl pyrrolidone solution, tetrachloroauric acid solution and ascorbic acid solution is 10:10:1:3:4 mg / ml; wherein the mass concentration of polyvinyl pyrrolidone solution and tetrachloroauric acid solution is 0.1%; In the step 1.4, the mass concentration ratio of the CdS@Au nanoparticle solution to the FA-PEG-SH solution is 2:1, and the volume ratio is 1:
1.
7. The method for preparing the circulating tumor cell detection kit according to claim 4, characterized in that: The preparation method of the Fe3O4@HA nano-capture probe is as follows: Step 2.1, add FeCl3.6H2O, FeCl2.4H2O and HA into a container, then add deionized water and stir evenly, then heat and reflux to 100 degrees Celsius under nitrogen protection and react for 15 minutes to obtain a mixed solution; Step 2.2, adding NaOH solution to the mixed solution, reacting at 100 degrees Celsius for 1 hour under nitrogen protection to obtain a reaction solution; Step 2.3, the reaction solution was transferred to a reactor and aged at 150°C for 24 h. After aging, the solution was placed in a dialysis bag and dialyzed for 2 days to obtain a Fe3O4@HA nano capture probe.
8. The method for preparing the circulating tumor cell detection kit according to claim 7, characterized in that: In the step 2.1, the mass volume ratio of FeCl3.6H2O, FeCl2.4H2O, HA and deionized water is 0.36:0.132:30:32.5 g / ml; In step 2.2, the mass ratio of the weight of NaOH to the mass of HA in the NaOH solution is 1000:
30.
9. A method for using the circulating tumor cell detection kit according to any one of claims 1 to 8, characterized in that: The steps include: S1, adding cancer cells to a multi-well plate for plating; S2, adding FA-CdS@Au nano-detection probe and Fe3O4@HA nano-capture probe, and then placing them in a shaker for incubation for 30 min, and then using magnetic separation to wash away the excess sample solution, and then adding PBS solution to obtain the solution to be tested, and then adding copper chloride solution to the solution to be tested, and then ultrasonically reacting for 10 min to obtain the detection solution; S3, testing the test solution: S3.1 When the detection method is photothermal method: irradiate the test solution with a 1064nm laser for 10-15min, use an infrared thermal imager to collect temperature changes and record the temperature difference; 3.2 When the detection method is the pressure method: weigh 20-100 mg of ammonium bicarbonate in a sealed pressure bottle, add the solution to be detected, irradiate with a 1064nm laser for 10-15 minutes, and use a barometer to record the pressure changes at different time periods.
10. The method for using the circulating tumor cell detection kit according to claim 9, characterized in that: In step S1, the cancer cell concentration is 10 cells / mL-10 W cells / mL; the concentration ratio of FA-CdS@Au nano-detection probe and Fe3O4@HA nano-capture probe is 800 μg / mL:200 μg / mL, and the volume ratio is 1:1; the added volume of FA-CdS@Au nano-detection probe and Fe3O4@HA nano-capture probe is 1-4:1; the volume ratio of FA-CdS@Au nano-detection probe to cancer cells is 1:9.
Citation Information
Patent Citations
Preparation method of hyaluronic acid modified superparamagnetic iron oxide / gold composite nanoprobe
CN104548142A
Folic acid functionalized and streptavidin modified magnetic nanoparticles, and preparation method and application thereof
CN110501208A
Photoelectrochemical biosensor as well as preparation method and application thereof
CN114137047A
CdS-coated Au nano composite material as well as preparation method and application thereof
CN117961059A
Cited By
Silicon dioxide-ferroferric oxide magnetic particles as well as preparation method and application thereof
CN120097354A
